# Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment

> **NCT02648022** · NA · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 83 (actual)

## Conditions studied

- Hepatitis C
- Depression
- PTSD
- Substance Use Disorder
- Fibrosis

## Interventions

- **BEHAVIORAL:** Brief mental health interventions and case management

## Key facts

- **NCT ID:** NCT02648022
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2014-02
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2016-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648022, "Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02648022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*